Metraipolis › archive › dc_1cdfe2becda9

Efficacy and safety of sintilimab combined with histology-specific chemotherapy in advanced NSCLC: a real-world retrospective study — Europe PMC PMID:42367283

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42367283
DOI: 10.3389/fphar.2026.1811195
License (as archived): solo-consultazione
Archived: 2026-10-31T13:47:02.617Z
SHA-256 of the archived text: b9d25be854cb43b87aabcd3f3e51499420d6c7e68d603df76f9f9bfc4ba799d2
Stable URL of this page: https://metraipolis.com/documento/dc_1cdfe2becda9

How to cite

Efficacy and safety of sintilimab combined with histology-specific chemotherapy in advanced NSCLC: a real-world retrospective study — Europe PMC PMID:42367283 — Europe PMC (en), https://europepmc.org/article/MED/42367283 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1cdfe2becda9 (Metraipolis archive dc_1cdfe2becda9, sha256 b9d25be854cb43b87aabcd3f3e51499420d6c7e68d603df76f9f9bfc4ba799d2)

BibTeX

@misc{dc1cdfe2becda9,
  title = {Efficacy and safety of sintilimab combined with histology-specific chemotherapy in advanced NSCLC: a real-world retrospective study — Europe PMC PMID:42367283},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367283},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1cdfe2becda9; sha256 b9d25be854cb43b87aabcd3f3e51499420d6c7e68d603df76f9f9bfc4ba799d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367283. Agents can read the archived copy with the MCP tool read_document.